Clinical Trial Update: BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration. [Phase 3]

View source ↗

Summary

This clinical trial update notes that BAY38-9456 (vardenafil HCl tablet) for erectile dysfunction in China has completed Phase 3 registration studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Vardenafil HCl Tablet (vardenafil hydrochloride)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED